Table 1.
Biophysical properties of scaffolds and scaffold-antibody interactions. ND, not done.
Molecule | Multimeric State | Tm (°C) |
ΔG (kcal mol-1) | SPR Motavizumab | NMR-HSQC Dispersion | ||
---|---|---|---|---|---|---|---|
kon (M-1s-1) | koff (s-1) | koff/kon (pM) | |||||
FFL_001 | Mon | 76 | ND | 3.99 × 106 | 1.19 × 10-4 | 29.9 | Dispersed |
FFL_002 | Mon | 49 | ND | 1.56 × 106 | 7.34 × 10-4 | 469.9 | ND |
FFL_004 | Mon | >85 | ND | 1.05 × 106 | 8.32 × 10-4 | 795.0 | ND |
FFL_005 | Mon | >100 | 15.0 | 2.97 × 106 | 2.09 × 10-4 | 70.3 | Partially Dispersed |
FFL_006 | Mon | >85 | ND | 3.57 × 106 | 2.32 × 10-4 | 651.9 | Dispersed |
FFL_007 | Mon | >85 | ND | 1.45 × 106 | 1.36 × 10-4 | 94.1 | Partially Dispersed |
FFL_001_surf1 | Mon | 84 | 8.2 | 7.43 × 106 | 4.70 × 10-4 | 6.32 | ND |
FFL_001_surf2 | Mon | >85 | 8.1 | 5.32 × 106 | 1.58 × 10-4 | 29.6 | ND |
FFL_001_surf4 | Mon | >85 | 9.0 | 4.80×106 | 1.58 × 10-4 | 32.9 | ND |